Webinar| Certification| MDR
In our free webinar on November 3, 2026, our expert Thora Markert, will discuss the implications of the EU AI Act for medical and in vitro diagnostic devices. Learn more about the current implementation status and the practical steps that manufacturers can take to prepare for the new requirements.
Register now free-of-charge
The implementation of the EU AI Act is now underway, and manufacturers of medical devices and in vitro diagnostic devices must begin preparing for a new set of regulatory requirements. AI systems used in medical devices are generally classified as high-risk AI systems, meaning that compliance with both the EU AI Act and the applicable MDR or IVDR requirements will become increasingly important.
For manufacturers of medical devices and in vitro diagnostics, this raises a set of important questions. In this free webinar, we will try to answer some of them. Our expert Thora Markert will provide an overview of the EU AI Act and its implementation timeline. You will gain insights into the regulatory requirements for AI medical devices and IVDs, the overlap between the EU AI Act and existing medical device legislation, and practical steps manufacturers can take to prepare for compliance.
Topics covered in this webinar:
Date: November 03, 2026
Time: 10:00– 11:00 (CET)
Fee: free
Language: English
This webinar is designed for medical device industry professionals and executives who deal with regulatory requirements, product classification, and conformity assessment procedures.
It is particularly suitable for:

With a background in medical AI to enhance healthcare solutions, Thora Markert studied Computer Science at the Free University of Bolzano in Italy. At TÜVIT, she served as Head of AI Research and Governance, working with federal offices in Germany to develop audit schemes and a technical testing framework for certifiable AI systems. Since October 2025, she has been Global Product Manager for AI at TÜV NORD CERT, focusing on developing and bringing AI certification schemes to global markets.